A patient with Hodgkin’s lymphoma is having a single cervical lymphnode. Biopsy showed lymphocyte predominant variant. Which of the following is the treatment of choice:
**Core Concept**
The lymphocyte-predominant variant of Hodgkin's lymphoma is a rare subtype characterized by a distinct immunophenotype and clinical behavior. It often presents with a limited number of lymph nodes involved, typically in the upper body, and has a favorable prognosis.
**Why the Correct Answer is Right**
The treatment of choice for lymphocyte-predominant Hodgkin's lymphoma (LPHL) is radiation therapy, often in the form of involved-field radiotherapy (IFRT). This approach takes advantage of the disease's tendency to be localized and its sensitivity to radiation. The goal of IFRT is to deliver a high dose of radiation to the involved lymph node(s) while minimizing exposure to surrounding tissues. The use of radiation therapy in LPHL has been shown to be highly effective in achieving long-term control of the disease.
**Why Each Wrong Option is Incorrect**
**Option A:** Chemotherapy is not the primary treatment for LPHL, although it may be used in certain cases, such as bulky disease or as part of an adjuvant treatment regimen.
**Option B:** Stem cell transplantation is not typically used as a first-line treatment for LPHL.
**Option C:** Surgery is not a standard treatment for LPHL, as the disease is responsive to radiation and chemotherapy, and surgical intervention is generally not necessary.
**Clinical Pearl / High-Yield Fact**
It's essential to recognize that LPHL has a distinct clinical behavior and prognosis compared to other subtypes of Hodgkin's lymphoma. Patients with LPHL tend to have a better response to treatment and a longer overall survival.
**Correct Answer: C. Radiation therapy is the treatment of choice for lymphocyte-predominant Hodgkin's lymphoma.**